The announcement came as the results from an earlier trial intended to prove the vaccine was safe and triggered antibody production were published. Or, if they do get infected, whether the vaccine prevents symptoms from developing. If they do get symptoms, the vaccine can still be considered a success if it stops severe cases of Covid-19. The announcement came shortly after the New England Journal of Medicine published results from the first stage of Moderna’s vaccine trial, which showed the first 45 participants all developed antibodies to the virus. Encouraging resultsModerna had previously published “interim results” from the first stages of its trial, called Phase 1 in May.

Source: Manila Times July 15, 2020 01:18 UTC